New-Onset Atrial Fibrillation in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Registry.
Anna G RosenblattColby R AyersAnjali RaoStacey J HowellNicholas S HendrenRonit H ZadikanyJoseph E EbingerJames D DanielsMark S LinkJames A de LemosSandeep R DasPublished in: Circulation. Arrhythmia and electrophysiology (2022)
New-onset AF was common (5.4%) among patients hospitalized with COVID-19. Almost half of patients with new-onset AF died during their index hospitalization. After multivariable adjustment for comorbidities and disease severity, new-onset AF was not statistically significantly associated with death, suggesting that new-onset AF in these patients may primarily be a marker of other adverse clinical factors rather than an independent driver of mortality. Causality between the MACE composites and AF needs to be further evaluated.
Keyphrases
- atrial fibrillation
- coronavirus disease
- end stage renal disease
- sars cov
- newly diagnosed
- ejection fraction
- chronic kidney disease
- heart failure
- left atrial
- catheter ablation
- prognostic factors
- oral anticoagulants
- peritoneal dialysis
- emergency department
- left atrial appendage
- coronary artery disease
- percutaneous coronary intervention
- cardiovascular disease
- cardiovascular events
- direct oral anticoagulants
- gold nanoparticles
- left ventricular
- respiratory syndrome coronavirus
- risk factors
- reduced graphene oxide